@article {Yerebakan:2007:0963-6897:935,
	author = "Yerebakan, Can and Kaminski, Alexander and Liebold, Andreas and Steinhoff, Gustav",
	title = "Safety of Intramyocardial Stem Cell Therapy for the Ischemic Myocardium: Results of the Rostock Trial After 5-Year Follow-Up",
	journal = "Cell Transplantation",
	volume = "16",
	number = "9",
	year = "2007",
	abstract = "Stem cell treatment for acute or chronic ischemic myocardium has gained major attention in the last decade. Experimental and clinical studies have shown evidence for functional improvement after cell-based treatments in acute or chronically ischemic jeopardized myocardium. Since 2001 we have performed bone marrow-derived CD133<SUP>&#43;</SUP> stem cell transplantations with concomitant coronary artery bypass surgery. Although our focus is mainly on the functional results of the stem cell treatment, possible long-term side effects of the new therapeutic strategy should also be addressed. Here we present for the first time the long-term follow-up safety results of the Rostock trial after direct intramyocardial stem cell treatment in 32 patients.",
	pages = "935-940",
	url = "http://www.ingentaconnect.com/content/cog/ct/2007/00000016/00000009/art00008",
	doi = "doi:10.3727/096368907783338280",
	keyword = "Stem cells, Myocardial regeneration, Myocardial ischemia, Cardiac surgery, Heart failure"
}